Process for determining the particle size distribution of an aerosol and apparatus for carrying out such a process

Abstract

The present invention provides, for the first time, a process that meets the needs of the drug industry for measuring the particle size of nebulised aerosols simultaneously or one after another by the laser diffraction method and the cascade impactor method which is known in the art. In this way it is possible to bring the reliability of the results of the laser diffraction process according to the invention into conformity with that of the cascade impactor, and thereby obtain a process which combines the advantages of the rapid laser diffraction process with the accuracy of the otherwise time-consuming cascade impactor method. In addition to the process, apparatus for carrying out the process are also disclosed.

1 . In a process for determining the size distribution of particles in an aerosol used to administer pharmaceutical formulations to the lung—which process uses either the laser diffraction or the scattered light method, the improvement which comprises adding a conditioning agent to the carrier medium of the aerosol to a given degree of saturation, mixing the conditioned carrier medium with a pharmaceutical formulation for administration, introducing the conditioned carrier medium with pharmaceutical formulation into at least one measuring cell in order, and determining the size distribution of the particles in such cell or cells.  
   
   
       2 . The process as recited in  claim 1 , wherein the pharmaceutical formulation is a solution, with active pharmaceutical substance or substances dissolved in a solvent.  
   
   
       3 . The process as recited in  claim 2 , wherein the solvent is used as the conditioning agent.  
   
   
       4 . The process as recited in  claim 1 , wherein the pharmaceutical formulation is a suspension with active pharmaceutical substance or substances in the form of particles in a liquid or gaseous medium.  
   
   
       5 . The process as recited in  claim 4 , wherein the liquid or gaseous medium is used as the conditioning agent.  
   
   
       6 . The process as recited in  claim 1 , wherein the pharmaceutical formulation is a powder comprising one or more active pharmaceutical substance.  
   
   
       7 . The process as recited in  claim 6 , wherein water is used as the conditioning agent.  
   
   
       8 . The process as recited in  claim 1 , wherein the carrier medium is air.  
   
   
       9 - 17 . (canceled)